Connection

Alistair Nichol to Histamine H2 Antagonists

Back to Details
This is a "connection" page, showing publications Alistair Nichol has written about Histamine H2 Antagonists.
Alistair Nichol
Connection Strength
0.171
Histamine H2 Antagonists
  1. A cluster randomised, crossover, registry-embedded clinical trial of proton pump inhibitors versus histamine-2 receptor blockers for ulcer prophylaxis therapy in the intensive care unit (PEPTIC study): study protocol. Crit Care Resusc. 2018 Sep; 20(3):182-189.
    View in: PubMed
    Score: 0.171
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.